Published in Cancer Weekly, July 16th, 2002
The research grant awarded by the Department of Health and Human Services of the National Institutes of Health (NIH) is designed to advance AuraZyme A- Z-CINN Linker technology. The A-Z-CINN Linker technology represents an opportunity to create a revolutionary drug delivery system...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.